Zygem Extraction Technology to be Used with Rubicon Kits | GenomeWeb

NEW YORK (GenomeWeb News) – Zygem and Rubicon Genomics have struck an agreement that will incorporate Zygem's enzymatic nucleic acid extraction technology with Rubicon's pre-analytical platform in an offering aimed at DNA and RNA analysis, Zygem said today.

The integration initially will focus on diagnostic single-cell whole genome amplification kits, but it could expand to include other research and diagnostic products, Zygem said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.